MAY 08, 2017 11:26 AM PDT

This Technique Makes Bones Transparent

WRITTEN BY: Xuan Pham

Scientists have developed a new method to make bones transparent. The technique, they say, will enable researchers to better understand bone biology as well as treat bone-related diseases, like osteoporosis.

Credit: Science Translational Medicine, Greenbaum, Chan, et al; Gradinaru laboratory/Caltech

The technique of making bones transparent is called Bone CLARITY, short for Clear Lipid-exchanged Acrylamide-hybridized Rigid Imaging/Immunostaining/In situ hybridization–compatible Tissue hYdrogel.

The team at the California Institute of Technology adapted CLARITY to bones by removing the calcium and washing away other components, like blood and fat, that typically make bones opaque. To keep the bone from turning into an indistinguishable gelatinous blob, the team used a hydrogel to maintain the bone’s structure. The process of making bones transparent is not an overnight job - it takes 28 days of constant chemical infusion and agitation.

But it’s worth the wait, say the researchers. Transparent bones can answer many questions about bone formation, some of which are crucial to treating fractures and even osteoporosis.

"Because of the sparsity of the stem cell population in the bone, it is challenging to extrapolate their numbers and positions from just a few slices of bone," says Alon Greenbaum, the co-first author of the study. "Additionally, slicing into bone causes deterioration and loses the complex and three-dimensional environment of the stem cell inside the bone. So there is a need to see inside intact tissue."

So far the Caltech team has been successful at transforming several mouse bones, including the femur, tibia, and bones in the vertebral column. A light-sheet microscope was built to visualize the clarity of these bones. Red fluorescent signals inside represent the bone stem cell population that have previously been difficult to pinpoint inside opaque bones.

Using what they learned about the stem cell population in transparent bones, the Caltech team collaborated with Amgen, a biotechnology company, to test a new compound that supposedly increased bone mass.  "We saw that indeed there was an increase in stem cells with this drug," said Ken Chan, the study’s other co-first author. "Monitoring stem cell responses to these kinds of drugs is crucial because early increases in proliferation are expected while new bone is being built, but long-term proliferation can lead to cancer."

The caveat of this technique is its limitations to mouse bone tissues so far. Large human bones would require new modifications and a longer period of incubation in the chemicals.

Additional source: Popular Science

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 23, 2018
Microbiology
JUN 23, 2018
In a First, Keystone Virus Sickens a Person
A teenage boy in North Central Florida presented with symptoms that defied diagnosis....
JUN 25, 2018
Microbiology
JUN 25, 2018
Gut Microbes Linked to Development of Liver Disease
The bacteria that live in our gut release compounds that might act as biomarkers, and may be a part of disease development....
JUL 11, 2018
Clinical & Molecular DX
JUL 11, 2018
Faster, cheaper TB test makes diagnosis easier in rural areas
  Scientists, working with doctors and public health researchers in South Africa, have created a new tuberculosis test that makes it easier to diagnos...
SEP 05, 2018
Clinical & Molecular DX
SEP 05, 2018
Iron-based MRI Contrast Outperforms Less Safe Method
A new method for loading iron inside nanoparticles creates MRI contrast agents that work better than the mainstay gadolinium chelates, which face increased...
SEP 15, 2018
Clinical & Molecular DX
SEP 15, 2018
Cancer & Anoikis: A Match Not Made in Heaven
Anoikis have always been intimately entwined with cancer, henceforth the quest to seek how they came to be as such....
NOV 13, 2018
Drug Discovery
NOV 13, 2018
Clinical Trial Drug For a Rare Neurodegenrative Disease Proven Unsuccessful
Niemann-Pick type C (NPC) is a rare and fatal neurodegenerative disease. Symptoms of the condition include loss of balance, difficulty swallowing, seizures...
Loading Comments...